nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP3A4—bone cancer	0.715	1	CbGaD
Tramadol—Venlafaxine—CYP3A4—bone cancer	0.00257	0.695	CrCbGaD
Tramadol—CYP2B6—Cisplatin—bone cancer	0.00249	0.455	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—bone cancer	0.00167	0.305	CbGbCtD
Tramadol—Dextromethorphan—CYP3A4—bone cancer	0.00112	0.305	CrCbGaD
Tramadol—CYP2D6—Doxorubicin—bone cancer	0.000808	0.147	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—bone cancer	0.000514	0.0936	CbGbCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000224	0.000839	CcSEcCtD
Tramadol—Hypersensitivity—Cisplatin—bone cancer	0.000224	0.000837	CcSEcCtD
Tramadol—Bradycardia—Epirubicin—bone cancer	0.000223	0.000836	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—bone cancer	0.000222	0.000832	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—bone cancer	0.000222	0.000829	CcSEcCtD
Tramadol—Haemoglobin—Epirubicin—bone cancer	0.000221	0.000825	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—bone cancer	0.000221	0.000825	CcSEcCtD
Tramadol—Rhinitis—Epirubicin—bone cancer	0.00022	0.000823	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—bone cancer	0.00022	0.000822	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—bone cancer	0.00022	0.000822	CcSEcCtD
Tramadol—Hepatitis—Epirubicin—bone cancer	0.000219	0.000821	CcSEcCtD
Tramadol—Haemorrhage—Epirubicin—bone cancer	0.000219	0.000821	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—bone cancer	0.000219	0.00082	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—bone cancer	0.000219	0.000818	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—bone cancer	0.000218	0.000817	CcSEcCtD
Tramadol—Asthenia—Cisplatin—bone cancer	0.000218	0.000815	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—bone cancer	0.000218	0.000815	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—bone cancer	0.000218	0.000814	CcSEcCtD
Tramadol—Sweating—Doxorubicin—bone cancer	0.000217	0.000811	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—bone cancer	0.000217	0.000811	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—bone cancer	0.000216	0.000809	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—bone cancer	0.000216	0.000807	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—bone cancer	0.000216	0.000807	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—bone cancer	0.000215	0.000805	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—bone cancer	0.000214	0.0008	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—bone cancer	0.000213	0.000798	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—bone cancer	0.000213	0.000796	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—bone cancer	0.000212	0.000794	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—bone cancer	0.000212	0.000792	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—bone cancer	0.000212	0.000791	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—bone cancer	0.000211	0.00079	CcSEcCtD
Tramadol—Chills—Methotrexate—bone cancer	0.00021	0.000787	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—bone cancer	0.000208	0.000777	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—bone cancer	0.000208	0.000776	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—bone cancer	0.000207	0.000773	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—bone cancer	0.000205	0.000768	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—bone cancer	0.000205	0.000767	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—bone cancer	0.000205	0.000765	CcSEcCtD
Tramadol—Erythema—Methotrexate—bone cancer	0.000204	0.000763	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—bone cancer	0.000204	0.000763	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—bone cancer	0.000204	0.000763	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—bone cancer	0.000204	0.000762	CcSEcCtD
Tramadol—Flushing—Epirubicin—bone cancer	0.000204	0.000762	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—bone cancer	0.000204	0.000761	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—bone cancer	0.000203	0.000759	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—bone cancer	0.000203	0.000759	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—bone cancer	0.000202	0.000756	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—bone cancer	0.000202	0.000754	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—bone cancer	0.000201	0.00075	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—bone cancer	0.0002	0.000748	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—bone cancer	0.0002	0.000748	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—bone cancer	0.0002	0.000746	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—bone cancer	0.000199	0.000745	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—bone cancer	0.000199	0.000744	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—bone cancer	0.000198	0.000741	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—bone cancer	0.000198	0.00074	CcSEcCtD
Tramadol—Back pain—Methotrexate—bone cancer	0.000197	0.000738	CcSEcCtD
Tramadol—Chills—Epirubicin—bone cancer	0.000197	0.000736	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—bone cancer	0.000196	0.000733	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—bone cancer	0.000196	0.000732	CcSEcCtD
Tramadol—Vomiting—Cisplatin—bone cancer	0.000193	0.000722	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—bone cancer	0.000192	0.000719	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—bone cancer	0.000192	0.000719	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—bone cancer	0.000192	0.000718	CcSEcCtD
Tramadol—Rash—Cisplatin—bone cancer	0.000191	0.000716	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—bone cancer	0.000191	0.000715	CcSEcCtD
Tramadol—Erythema—Epirubicin—bone cancer	0.000191	0.000714	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—bone cancer	0.000191	0.000714	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—bone cancer	0.00019	0.00071	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—bone cancer	0.000189	0.000708	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—bone cancer	0.000189	0.000708	CcSEcCtD
Tramadol—Anaemia—Methotrexate—bone cancer	0.000189	0.000706	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—bone cancer	0.000188	0.000705	CcSEcCtD
Tramadol—Flushing—Doxorubicin—bone cancer	0.000188	0.000705	CcSEcCtD
Tramadol—Flatulence—Epirubicin—bone cancer	0.000188	0.000704	CcSEcCtD
Tramadol—Tension—Epirubicin—bone cancer	0.000187	0.000701	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—bone cancer	0.000187	0.0007	CcSEcCtD
Tramadol—Nervousness—Epirubicin—bone cancer	0.000186	0.000694	CcSEcCtD
Tramadol—Back pain—Epirubicin—bone cancer	0.000185	0.000691	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—bone cancer	0.000184	0.000689	CcSEcCtD
Tramadol—Malaise—Methotrexate—bone cancer	0.000184	0.000688	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—bone cancer	0.000184	0.000687	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—bone cancer	0.000183	0.000686	CcSEcCtD
Tramadol—Vertigo—Methotrexate—bone cancer	0.000183	0.000686	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—bone cancer	0.000183	0.000684	CcSEcCtD
Tramadol—Chills—Doxorubicin—bone cancer	0.000182	0.000681	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—bone cancer	0.000181	0.000678	CcSEcCtD
Tramadol—Nausea—Cisplatin—bone cancer	0.00018	0.000674	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—bone cancer	0.00018	0.000673	CcSEcCtD
Tramadol—Cough—Methotrexate—bone cancer	0.000178	0.000666	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—bone cancer	0.000178	0.000665	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—bone cancer	0.000177	0.000663	CcSEcCtD
Tramadol—Convulsion—Methotrexate—bone cancer	0.000177	0.000661	CcSEcCtD
Tramadol—Erythema—Doxorubicin—bone cancer	0.000177	0.000661	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—bone cancer	0.000177	0.000661	CcSEcCtD
Tramadol—Anaemia—Epirubicin—bone cancer	0.000177	0.00066	CcSEcCtD
Tramadol—Agitation—Epirubicin—bone cancer	0.000176	0.000657	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—bone cancer	0.000174	0.000651	CcSEcCtD
Tramadol—Myalgia—Methotrexate—bone cancer	0.000174	0.00065	CcSEcCtD
Tramadol—Chest pain—Methotrexate—bone cancer	0.000174	0.00065	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—bone cancer	0.000174	0.00065	CcSEcCtD
Tramadol—Tension—Doxorubicin—bone cancer	0.000173	0.000649	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—bone cancer	0.000173	0.000647	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000173	0.000645	CcSEcCtD
Tramadol—Malaise—Epirubicin—bone cancer	0.000172	0.000644	CcSEcCtD
Tramadol—Discomfort—Methotrexate—bone cancer	0.000172	0.000642	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—bone cancer	0.000172	0.000642	CcSEcCtD
Tramadol—Vertigo—Epirubicin—bone cancer	0.000172	0.000642	CcSEcCtD
Tramadol—Syncope—Epirubicin—bone cancer	0.000171	0.000641	CcSEcCtD
Tramadol—Back pain—Doxorubicin—bone cancer	0.000171	0.000639	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—bone cancer	0.00017	0.000636	CcSEcCtD
Tramadol—Palpitations—Epirubicin—bone cancer	0.000169	0.000631	CcSEcCtD
Tramadol—Confusional state—Methotrexate—bone cancer	0.000168	0.000628	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—bone cancer	0.000168	0.000628	CcSEcCtD
Tramadol—Cough—Epirubicin—bone cancer	0.000167	0.000623	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—bone cancer	0.000167	0.000623	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—bone cancer	0.000167	0.000623	CcSEcCtD
Tramadol—Convulsion—Epirubicin—bone cancer	0.000166	0.000619	CcSEcCtD
Tramadol—Infection—Methotrexate—bone cancer	0.000166	0.000619	CcSEcCtD
Tramadol—Hypertension—Epirubicin—bone cancer	0.000165	0.000617	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—bone cancer	0.000164	0.000613	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—bone cancer	0.000163	0.000611	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—bone cancer	0.000163	0.000611	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—bone cancer	0.000163	0.00061	CcSEcCtD
Tramadol—Chest pain—Epirubicin—bone cancer	0.000163	0.000608	CcSEcCtD
Tramadol—Myalgia—Epirubicin—bone cancer	0.000163	0.000608	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—bone cancer	0.000163	0.000608	CcSEcCtD
Tramadol—Agitation—Doxorubicin—bone cancer	0.000162	0.000607	CcSEcCtD
Tramadol—Anxiety—Epirubicin—bone cancer	0.000162	0.000606	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—bone cancer	0.000162	0.000605	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000162	0.000604	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—bone cancer	0.000161	0.000602	CcSEcCtD
Tramadol—Discomfort—Epirubicin—bone cancer	0.000161	0.000601	CcSEcCtD
Tramadol—Malaise—Doxorubicin—bone cancer	0.000159	0.000596	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—bone cancer	0.000159	0.000595	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—bone cancer	0.000159	0.000594	CcSEcCtD
Tramadol—Anorexia—Methotrexate—bone cancer	0.000159	0.000594	CcSEcCtD
Tramadol—Syncope—Doxorubicin—bone cancer	0.000159	0.000593	CcSEcCtD
Tramadol—Confusional state—Epirubicin—bone cancer	0.000157	0.000588	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—bone cancer	0.000156	0.000584	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—bone cancer	0.000156	0.000583	CcSEcCtD
Tramadol—Hypotension—Methotrexate—bone cancer	0.000156	0.000582	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—bone cancer	0.000155	0.000581	CcSEcCtD
Tramadol—Infection—Epirubicin—bone cancer	0.000155	0.000579	CcSEcCtD
Tramadol—Cough—Doxorubicin—bone cancer	0.000154	0.000577	CcSEcCtD
Tramadol—Shock—Epirubicin—bone cancer	0.000153	0.000574	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—bone cancer	0.000153	0.000573	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—bone cancer	0.000153	0.000572	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—bone cancer	0.000153	0.000571	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—bone cancer	0.000153	0.000571	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—bone cancer	0.000152	0.000569	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000152	0.000568	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—bone cancer	0.000151	0.000566	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—bone cancer	0.000151	0.000564	CcSEcCtD
Tramadol—Insomnia—Methotrexate—bone cancer	0.000151	0.000564	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—bone cancer	0.000151	0.000563	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—bone cancer	0.000151	0.000563	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—bone cancer	0.000151	0.000563	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—bone cancer	0.00015	0.000561	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—bone cancer	0.00015	0.000559	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000149	0.000559	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—bone cancer	0.000149	0.000556	CcSEcCtD
Tramadol—Anorexia—Epirubicin—bone cancer	0.000149	0.000556	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—bone cancer	0.000149	0.000555	CcSEcCtD
Tramadol—Somnolence—Methotrexate—bone cancer	0.000148	0.000554	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—bone cancer	0.000147	0.00055	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—bone cancer	0.000147	0.000548	CcSEcCtD
Tramadol—Hypotension—Epirubicin—bone cancer	0.000146	0.000545	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—bone cancer	0.000145	0.000544	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—bone cancer	0.000145	0.000542	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—bone cancer	0.000144	0.00054	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000144	0.000538	CcSEcCtD
Tramadol—Fatigue—Methotrexate—bone cancer	0.000144	0.000537	CcSEcCtD
Tramadol—Infection—Doxorubicin—bone cancer	0.000143	0.000536	CcSEcCtD
Tramadol—Pain—Methotrexate—bone cancer	0.000142	0.000533	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000142	0.000531	CcSEcCtD
Tramadol—Shock—Doxorubicin—bone cancer	0.000142	0.000531	CcSEcCtD
Tramadol—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000142	0.0174	CbGpPWpGaD
Tramadol—Nervous system disorder—Doxorubicin—bone cancer	0.000142	0.000529	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—bone cancer	0.000141	0.000528	CcSEcCtD
Tramadol—Insomnia—Epirubicin—bone cancer	0.000141	0.000527	CcSEcCtD
Tramadol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000141	0.0173	CbGpPWpGaD
Tramadol—Tachycardia—Doxorubicin—bone cancer	0.000141	0.000527	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—bone cancer	0.00014	0.000524	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—bone cancer	0.00014	0.000524	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—bone cancer	0.000139	0.000522	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—bone cancer	0.000139	0.00052	CcSEcCtD
Tramadol—Somnolence—Epirubicin—bone cancer	0.000139	0.000518	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—bone cancer	0.000138	0.000514	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—bone cancer	0.000137	0.000513	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—bone cancer	0.000137	0.000513	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—bone cancer	0.000136	0.000509	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—bone cancer	0.000136	0.000507	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—bone cancer	0.000135	0.000504	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000135	0.000503	CcSEcCtD
Tramadol—Fatigue—Epirubicin—bone cancer	0.000134	0.000503	CcSEcCtD
Tramadol—Pain—Epirubicin—bone cancer	0.000133	0.000499	CcSEcCtD
Tramadol—Constipation—Epirubicin—bone cancer	0.000133	0.000499	CcSEcCtD
Tramadol—Urticaria—Methotrexate—bone cancer	0.000132	0.000495	CcSEcCtD
Tramadol—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000132	0.0163	CbGpPWpGaD
Tramadol—Body temperature increased—Methotrexate—bone cancer	0.000132	0.000493	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—bone cancer	0.000132	0.000493	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000131	0.000492	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—bone cancer	0.000131	0.000488	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—bone cancer	0.00013	0.000484	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—bone cancer	0.000129	0.000481	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—bone cancer	0.000129	0.00048	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—bone cancer	0.000128	0.00048	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—bone cancer	0.000128	0.000477	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—bone cancer	0.000127	0.000475	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—bone cancer	0.000125	0.000469	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000125	0.000466	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—bone cancer	0.000124	0.000465	CcSEcCtD
Tramadol—Urticaria—Epirubicin—bone cancer	0.000124	0.000463	CcSEcCtD
Tramadol—Constipation—Doxorubicin—bone cancer	0.000123	0.000461	CcSEcCtD
Tramadol—Pain—Doxorubicin—bone cancer	0.000123	0.000461	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—bone cancer	0.000123	0.000461	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—bone cancer	0.000123	0.000461	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—bone cancer	0.000123	0.000459	CcSEcCtD
Tramadol—Asthenia—Methotrexate—bone cancer	0.00012	0.000447	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—bone cancer	0.000119	0.000445	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000118	0.000441	CcSEcCtD
Tramadol—Pruritus—Methotrexate—bone cancer	0.000118	0.000441	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—bone cancer	0.000115	0.00043	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—bone cancer	0.000115	0.000429	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—bone cancer	0.000114	0.000426	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—bone cancer	0.000114	0.000426	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—bone cancer	0.000114	0.000426	CcSEcCtD
Tramadol—Asthenia—Epirubicin—bone cancer	0.000112	0.000418	CcSEcCtD
Tramadol—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000111	0.0136	CbGpPWpGaD
Tramadol—Pruritus—Epirubicin—bone cancer	0.00011	0.000413	CcSEcCtD
Tramadol—Dizziness—Methotrexate—bone cancer	0.00011	0.000412	CcSEcCtD
Tramadol—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000109	0.0134	CbGpPWpGaD
Tramadol—Diarrhoea—Epirubicin—bone cancer	0.000107	0.000399	CcSEcCtD
Tramadol—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000106	0.0131	CbGpPWpGaD
Tramadol—Hypersensitivity—Doxorubicin—bone cancer	0.000106	0.000397	CcSEcCtD
Tramadol—Vomiting—Methotrexate—bone cancer	0.000106	0.000396	CcSEcCtD
Tramadol—Rash—Methotrexate—bone cancer	0.000105	0.000393	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—bone cancer	0.000105	0.000392	CcSEcCtD
Tramadol—Headache—Methotrexate—bone cancer	0.000104	0.00039	CcSEcCtD
Tramadol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000104	0.0128	CbGpPWpGaD
Tramadol—Asthenia—Doxorubicin—bone cancer	0.000104	0.000387	CcSEcCtD
Tramadol—Dizziness—Epirubicin—bone cancer	0.000103	0.000386	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—bone cancer	0.000102	0.000382	CcSEcCtD
Tramadol—Vomiting—Epirubicin—bone cancer	9.91e-05	0.000371	CcSEcCtD
Tramadol—Nausea—Methotrexate—bone cancer	9.9e-05	0.00037	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—bone cancer	9.87e-05	0.000369	CcSEcCtD
Tramadol—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	9.86e-05	0.0121	CbGpPWpGaD
Tramadol—Rash—Epirubicin—bone cancer	9.83e-05	0.000368	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—bone cancer	9.82e-05	0.000367	CcSEcCtD
Tramadol—Headache—Epirubicin—bone cancer	9.77e-05	0.000365	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—bone cancer	9.54e-05	0.000357	CcSEcCtD
Tramadol—CHRM3—GPCRs, Other—GRM1—bone cancer	9.42e-05	0.0116	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—GRM4—bone cancer	9.28e-05	0.0114	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—RGS1—bone cancer	9.28e-05	0.0114	CbGpPWpGaD
Tramadol—Nausea—Epirubicin—bone cancer	9.26e-05	0.000346	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—bone cancer	9.17e-05	0.000343	CcSEcCtD
Tramadol—Rash—Doxorubicin—bone cancer	9.1e-05	0.00034	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—bone cancer	9.09e-05	0.00034	CcSEcCtD
Tramadol—Headache—Doxorubicin—bone cancer	9.04e-05	0.000338	CcSEcCtD
Tramadol—Nausea—Doxorubicin—bone cancer	8.57e-05	0.00032	CcSEcCtD
Tramadol—OPRK1—G alpha (i) signalling events—GRM4—bone cancer	8.14e-05	0.01	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—RGS1—bone cancer	8.14e-05	0.01	CbGpPWpGaD
Tramadol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	8.09e-05	0.00995	CbGpPWpGaD
Tramadol—CHRM3—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	7.32e-05	0.009	CbGpPWpGaD
Tramadol—CHRM3—Regulation of insulin secretion—GNA11—bone cancer	6.94e-05	0.00853	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	6.88e-05	0.00846	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	6.88e-05	0.00846	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—SMO—bone cancer	6.64e-05	0.00816	CbGpPWpGaD
Tramadol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	6.61e-05	0.00812	CbGpPWpGaD
Tramadol—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	6.52e-05	0.00802	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	6.45e-05	0.00793	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—GRM1—bone cancer	6.15e-05	0.00756	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—GRM4—bone cancer	5.62e-05	0.00691	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	5.5e-05	0.00676	CbGpPWpGaD
Tramadol—CHRM3—Integration of energy metabolism—GNA11—bone cancer	5.45e-05	0.00671	CbGpPWpGaD
Tramadol—SLC6A4—NRF2 pathway—TGFBR2—bone cancer	5.4e-05	0.00664	CbGpPWpGaD
Tramadol—SLC6A4—NRF2 pathway—GSTP1—bone cancer	5.4e-05	0.00664	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—GNA11—bone cancer	5.4e-05	0.00664	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—EZH2—bone cancer	5.37e-05	0.00661	CbGpPWpGaD
Tramadol—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	5.36e-05	0.00659	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—GRM1—bone cancer	5.29e-05	0.00651	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—GRM4—bone cancer	4.93e-05	0.00606	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—GRM1—bone cancer	4.87e-05	0.00599	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	4.73e-05	0.00582	CbGpPWpGaD
Tramadol—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	4.65e-05	0.00571	CbGpPWpGaD
Tramadol—SLC6A2—NRF2 pathway—GSTP1—bone cancer	4.65e-05	0.00571	CbGpPWpGaD
Tramadol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.59e-05	0.00565	CbGpPWpGaD
Tramadol—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.53e-05	0.00557	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—GRM1—bone cancer	4.27e-05	0.00525	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—GRM4—bone cancer	4.16e-05	0.00512	CbGpPWpGaD
Tramadol—CHRM3—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	4.09e-05	0.00503	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—GNA11—bone cancer	3.96e-05	0.00487	CbGpPWpGaD
Tramadol—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.72e-05	0.00458	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.65e-05	0.00449	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—GRM1—bone cancer	3.61e-05	0.00444	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—GRM4—bone cancer	3.58e-05	0.0044	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	3.54e-05	0.00436	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—SMO—bone cancer	3.43e-05	0.00422	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—GNA11—bone cancer	3.41e-05	0.0042	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GRM4—bone cancer	3.18e-05	0.00391	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—RGS1—bone cancer	3.18e-05	0.00391	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.15e-05	0.00388	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—GRM1—bone cancer	3.1e-05	0.00381	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—GRM4—bone cancer	3.08e-05	0.00379	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	3.05e-05	0.00375	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	3.03e-05	0.00373	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—SMO—bone cancer	3.01e-05	0.0037	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—JUN—bone cancer	3e-05	0.00369	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—RGS1—bone cancer	2.88e-05	0.00355	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GRM4—bone cancer	2.88e-05	0.00355	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—CYP3A4—bone cancer	2.84e-05	0.0035	CbGpPWpGaD
Tramadol—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	2.81e-05	0.00345	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GRM4—bone cancer	2.78e-05	0.00342	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—RGS1—bone cancer	2.78e-05	0.00342	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GRM1—bone cancer	2.75e-05	0.00339	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—GRM1—bone cancer	2.67e-05	0.00328	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—SMO—bone cancer	2.54e-05	0.00313	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GRM4—bone cancer	2.53e-05	0.00311	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—RGS1—bone cancer	2.53e-05	0.00311	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GRM1—bone cancer	2.5e-05	0.00308	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—GSTP1—bone cancer	2.43e-05	0.00299	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GRM1—bone cancer	2.41e-05	0.00297	CbGpPWpGaD
Tramadol—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	2.4e-05	0.00295	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	2.39e-05	0.00294	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GRM4—bone cancer	2.35e-05	0.00289	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—RGS1—bone cancer	2.35e-05	0.00289	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GRM1—bone cancer	2.19e-05	0.0027	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—SMO—bone cancer	2.18e-05	0.00269	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RGS1—bone cancer	2.14e-05	0.00263	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GRM4—bone cancer	2.14e-05	0.00263	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GRM1—bone cancer	2.04e-05	0.00251	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—BRAF—bone cancer	2.03e-05	0.0025	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—RGS1—bone cancer	2.02e-05	0.00249	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GRM4—bone cancer	2.02e-05	0.00249	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NDUFA12—bone cancer	1.98e-05	0.00244	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—CYP3A4—bone cancer	1.98e-05	0.00243	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—JUN—bone cancer	1.95e-05	0.0024	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	1.95e-05	0.0024	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—SMO—bone cancer	1.88e-05	0.00231	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GRM1—bone cancer	1.85e-05	0.00228	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RGS1—bone cancer	1.84e-05	0.00226	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GRM4—bone cancer	1.84e-05	0.00226	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GNA11—bone cancer	1.77e-05	0.00218	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—SMO—bone cancer	1.76e-05	0.00217	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GRM1—bone cancer	1.75e-05	0.00216	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GRM4—bone cancer	1.74e-05	0.00214	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—RGS1—bone cancer	1.74e-05	0.00214	CbGpPWpGaD
Tramadol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.71e-05	0.0021	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NDUFA12—bone cancer	1.71e-05	0.0021	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GRM4—bone cancer	1.7e-05	0.0021	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RGS1—bone cancer	1.7e-05	0.0021	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—GSTP1—bone cancer	1.69e-05	0.00208	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	1.67e-05	0.00205	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NT5C3A—bone cancer	1.64e-05	0.00202	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GNA11—bone cancer	1.61e-05	0.00198	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL3—bone cancer	1.61e-05	0.00198	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GRM1—bone cancer	1.59e-05	0.00196	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GRM4—bone cancer	1.58e-05	0.00194	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RGS1—bone cancer	1.58e-05	0.00194	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GNA11—bone cancer	1.56e-05	0.00191	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—SMO—bone cancer	1.54e-05	0.0019	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GRM1—bone cancer	1.51e-05	0.00186	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GRM4—bone cancer	1.49e-05	0.00184	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RGS1—bone cancer	1.49e-05	0.00184	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GRM1—bone cancer	1.48e-05	0.00182	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL3—bone cancer	1.46e-05	0.0018	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GNA11—bone cancer	1.41e-05	0.00174	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NT5C3A—bone cancer	1.41e-05	0.00174	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL3—bone cancer	1.41e-05	0.00173	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GRM1—bone cancer	1.37e-05	0.00168	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GNA11—bone cancer	1.31e-05	0.00162	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—SMO—bone cancer	1.31e-05	0.00161	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GRM1—bone cancer	1.3e-05	0.00159	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—bone cancer	1.29e-05	0.00159	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL3—bone cancer	1.28e-05	0.00158	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GRM4—bone cancer	1.26e-05	0.00155	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RGS1—bone cancer	1.26e-05	0.00155	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GNA11—bone cancer	1.19e-05	0.00147	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL3—bone cancer	1.19e-05	0.00147	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NDUFA12—bone cancer	1.19e-05	0.00146	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—bone cancer	1.16e-05	0.00143	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GNA11—bone cancer	1.13e-05	0.00139	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—SMO—bone cancer	1.12e-05	0.00138	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.11e-05	0.00136	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GRM1—bone cancer	1.09e-05	0.00135	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.09e-05	0.00134	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RGS1—bone cancer	1.08e-05	0.00133	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GRM4—bone cancer	1.08e-05	0.00133	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL3—bone cancer	1.08e-05	0.00133	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SMO—bone cancer	1.04e-05	0.00128	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNA11—bone cancer	1.03e-05	0.00126	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL3—bone cancer	1.02e-05	0.00126	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.01e-05	0.00124	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NT5C3A—bone cancer	9.82e-06	0.00121	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNA11—bone cancer	9.72e-06	0.0012	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—SMO—bone cancer	9.65e-06	0.00119	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNA11—bone cancer	9.52e-06	0.00117	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GRM1—bone cancer	9.4e-06	0.00116	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RGS1—bone cancer	9.33e-06	0.00115	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GRM4—bone cancer	9.33e-06	0.00115	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL3—bone cancer	9.3e-06	0.00114	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SMO—bone cancer	9.13e-06	0.00112	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ATF1—bone cancer	8.85e-06	0.00109	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNA11—bone cancer	8.83e-06	0.00109	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL3—bone cancer	8.81e-06	0.00108	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	8.69e-06	0.00107	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL3—bone cancer	8.63e-06	0.00106	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNA11—bone cancer	8.35e-06	0.00103	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GRM1—bone cancer	8.09e-06	0.000995	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL3—bone cancer	8e-06	0.000984	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ATF1—bone cancer	7.76e-06	0.000954	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NDUFA12—bone cancer	7.75e-06	0.000953	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SMO—bone cancer	7.71e-06	0.000949	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL3—bone cancer	7.57e-06	0.000931	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFBR2—bone cancer	7.38e-06	0.000908	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO2—bone cancer	7.19e-06	0.000885	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNA11—bone cancer	7.05e-06	0.000868	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF1R—bone cancer	6.94e-06	0.000854	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—DHFR—bone cancer	6.67e-06	0.000821	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SMO—bone cancer	6.62e-06	0.000815	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ATF1—bone cancer	6.56e-06	0.000806	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFBR2—bone cancer	6.47e-06	0.000796	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NT5C3A—bone cancer	6.42e-06	0.00079	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL3—bone cancer	6.4e-06	0.000786	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNA11—bone cancer	6.24e-06	0.000767	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO2—bone cancer	6.19e-06	0.000761	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1R—bone cancer	6.09e-06	0.000749	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNA11—bone cancer	6.06e-06	0.000745	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—DHFR—bone cancer	5.74e-06	0.000706	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SMO—bone cancer	5.7e-06	0.000701	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP3A4—bone cancer	5.65e-06	0.000695	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ATF1—bone cancer	5.63e-06	0.000693	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL3—bone cancer	5.49e-06	0.000675	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFBR2—bone cancer	5.47e-06	0.000673	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNA11—bone cancer	5.37e-06	0.00066	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNA11—bone cancer	5.22e-06	0.000641	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1R—bone cancer	5.15e-06	0.000633	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KIT—bone cancer	5.04e-06	0.000619	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP3A4—bone cancer	4.86e-06	0.000598	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ATF1—bone cancer	4.85e-06	0.000596	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTP1—bone cancer	4.84e-06	0.000595	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BRAF—bone cancer	4.73e-06	0.000582	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL3—bone cancer	4.73e-06	0.000581	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFBR2—bone cancer	4.7e-06	0.000578	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—bone cancer	4.59e-06	0.000564	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1R—bone cancer	4.42e-06	0.000543	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KIT—bone cancer	4.42e-06	0.000543	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO2—bone cancer	4.3e-06	0.000529	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTP1—bone cancer	4.16e-06	0.000512	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BRAF—bone cancer	4.15e-06	0.00051	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFBR2—bone cancer	4.04e-06	0.000497	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—bone cancer	4.02e-06	0.000495	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—DHFR—bone cancer	3.99e-06	0.000491	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MDM2—bone cancer	3.97e-06	0.000488	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1R—bone cancer	3.8e-06	0.000468	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KIT—bone cancer	3.73e-06	0.000459	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNA11—bone cancer	3.73e-06	0.000459	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—bone cancer	3.51e-06	0.000431	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MDM2—bone cancer	3.48e-06	0.000428	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—JUN—bone cancer	3.45e-06	0.000424	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—bone cancer	3.4e-06	0.000418	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP3A4—bone cancer	3.38e-06	0.000416	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—bone cancer	3.35e-06	0.000412	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIT—bone cancer	3.2e-06	0.000394	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—bone cancer	3.02e-06	0.000372	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—bone cancer	3.01e-06	0.00037	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—bone cancer	2.94e-06	0.000362	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—bone cancer	2.94e-06	0.000361	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—bone cancer	2.92e-06	0.000359	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—bone cancer	2.89e-06	0.000356	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—bone cancer	2.81e-06	0.000346	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIT—bone cancer	2.76e-06	0.000339	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—bone cancer	2.71e-06	0.000333	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—DHFR—bone cancer	2.61e-06	0.000321	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—bone cancer	2.59e-06	0.000319	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—bone cancer	2.55e-06	0.000314	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—bone cancer	2.52e-06	0.00031	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—bone cancer	2.51e-06	0.000309	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—bone cancer	2.51e-06	0.000308	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—bone cancer	2.49e-06	0.000306	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNA11—bone cancer	2.44e-06	0.0003	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—bone cancer	2.38e-06	0.000292	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—bone cancer	2.28e-06	0.00028	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—bone cancer	2.19e-06	0.00027	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—bone cancer	2.17e-06	0.000267	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—bone cancer	2.16e-06	0.000265	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—bone cancer	2.13e-06	0.000263	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—bone cancer	2.01e-06	0.000247	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—bone cancer	2e-06	0.000245	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—bone cancer	1.89e-06	0.000233	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—bone cancer	1.89e-06	0.000232	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—bone cancer	1.84e-06	0.000226	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—bone cancer	1.72e-06	0.000212	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—bone cancer	1.69e-06	0.000207	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—bone cancer	1.5e-06	0.000184	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—bone cancer	1.49e-06	0.000183	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—bone cancer	1.45e-06	0.000178	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—bone cancer	1.25e-06	0.000153	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—bone cancer	9.79e-07	0.00012	CbGpPWpGaD
